Longevity Health Holdings, Inc.
XAGE
$2.41
-$0.06-2.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 560.70K | 50.30K | 32.80K | 3.74M | 3.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 560.70K | 50.30K | 32.80K | 3.74M | 3.73M |
| Cost of Revenue | 246.80K | 6.30K | 5.10K | 300.00 | -- |
| Gross Profit | 313.80K | 44.00K | 27.70K | 12.00K | -- |
| SG&A Expenses | 4.53M | 3.90M | 4.06M | 3.48M | 3.04M |
| Depreciation & Amortization | 83.90K | 83.40K | 88.60K | 93.80K | 96.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.69M | 5.05M | 4.36M | 5.04M | 5.32M |
| Operating Income | -5.13M | -5.00M | -4.32M | -5.03M | -5.32M |
| Income Before Tax | -8.70M | -10.75M | -9.75M | -15.93M | -17.93M |
| Income Tax Expenses | -97.30K | -97.30K | -- | -- | -- |
| Earnings from Continuing Operations | -8.60 | -10.65 | -9.75 | -15.93 | -17.93 |
| Earnings from Discontinued Operations | 0.00 | 282.20K | 3.45M | 1.04M | 1.04M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.60M | -10.37M | -6.30M | -14.88M | -16.89M |
| EBIT | -5.13M | -5.00M | -4.32M | -5.03M | -5.32M |
| EBITDA | -5.04M | -4.92M | -4.24M | -4.93M | -5.23M |
| EPS Basic | -11.74 | -14.51 | -9.16 | -23.57 | -168.83 |
| Normalized Basic EPS | -7.39 | -9.34 | -8.44 | -14.29 | -99.81 |
| EPS Diluted | -11.74 | -14.51 | -9.16 | -23.57 | -168.83 |
| Normalized Diluted EPS | -7.39 | -9.34 | -8.44 | -14.29 | -99.81 |
| Average Basic Shares Outstanding | 3.08M | 2.85M | 2.93M | 2.86M | 2.20M |
| Average Diluted Shares Outstanding | 3.08M | 2.85M | 2.93M | 2.86M | 2.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |